Loading patent…
AssigneeBetz Laboratories, Inc.
InventorsWilson K. Whitekettle, Deborah K. Donofrio
Estimating the term…
Bactericidal composition and method for inhibiting and controlling the growth of the capsulated, facultative bacterium, Klebsiella pneumoniae, are disclosed. The composition comprises an amount, effective for the intended purpose, of 2-bromo-2-nitropropane-1,3-diol (BNPD) and "Belclene 350." The active biocidal component of the "Belclene 350" product is tri n-butyl tetradecyl phosphonium chloride. The method comprises administering between about 0.1 to about 200 parts of this composition (i.e., BNPD and "Belclene 350" product) (based on one million parts of the desired aqueous system) to the particular water containing system for which treatment is desired.
A bacterial inhibiting composition comprising a synergistic aqueous mixture of (a) 2-bromo-2-nitropropane-1,3-diol (BNPD) and (b) tri n-butyl tetradecyl phosphonium chloride, the weight ratio of (a):(b) being from about 2:1 to about 1:16.
A method for controlling the growth of Klebsiella pneumoniae bacteria in an aqueous system which comprises adding to said system from about 0.1 to about 200 parts per weight of a synergistic composition per one million parts per weight of said aqueous system, said composition comprising (a) 2-bromo-2-nitropropane-1,3-diol (BNPD), and (b) tri n-butyl tetradecyl phosphonium chloride, the weight ratio of (a):(b) being from about 2:1 to about 1:16.
Dependencies are inferred from the claim text.